According to Aeterna Zentaris's latest financial reports and stock price the company's current number of shares outstanding is 4,855,876. At the end of 2023 the company had 4,855,876 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 4.85 M | -0.16% |
2022 | 4.86 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
![]() Novartis NVS | 2,062,000,000 | 42,364.02% | ๐จ๐ญ Switzerland |
![]() Sanofi SNY | 2,506,400,000 | 51,515.82% | ๐ซ๐ท France |
![]() Bristol-Myers Squibb BMY | 2,057,000,000 | 42,261.05% | ๐บ๐ธ USA |
![]() Spectrum Pharmaceuticals
SPPI | 201,918,066 | 4,058.22% | ๐บ๐ธ USA |
![]() Halozyme Therapeutics HALO | 131,965,000 | 2,617.64% | ๐บ๐ธ USA |